CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/19/2024
Back to search
Official data from USPTO
IZONRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/19/2024
Trademark type
Word
Nice classes
5
Filing date
07/14/2022
Registration date
08/08/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2023
Last transaction
08/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
COGAN, BRITTNEY
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sandoz AG
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
28 publications found
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/13/2023
FIMP
FINAL DISPOSITION PROCESSED
11/13/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/08/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/23/2023
PUBO
PUBLISHED FOR OPPOSITION
05/23/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/03/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2023
ALIE
ASSIGNED TO LIE
04/17/2023
RFNT
REFUSAL PROCESSED BY IB
02/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/18/2023
RFRR
REFUSAL PROCESSED BY MPU
01/18/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/08/2022
CNRT
NON-FINAL ACTION WRITTEN
11/07/2022
DOCK
ASSIGNED TO EXAMINER
11/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/20/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/13/2022
Continuous trademark protection
Get notified about every new filing that threatens IZONRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.